Henning Boldt

Medicine & Life Sciences

1. Glioblastoma 100%
2. Glioma 76%
3. DNA Methylation 68%
4. Methylation 53%
5. Brain Neoplasms 41%
6. SB 747651A 37%
7. Neoplasms 37%
8. Pituitary Neoplasms 37%
9. Central Nervous System Neoplasms 36%
10. ATR-X syndrome 36%
11. Mutation 34%
12. Early Growth Response Protein 3 33%
13. Corticotrophs 30%
14. Junctional Adhesion Molecule A 28%
15. High-Throughput Nucleotide Sequencing 26%
16. Early Growth Response Protein 1 25%
17. Protein Methyltransferases 24%
18. Supratentorial Neoplasms 24%
19. Agrin 24%
20. Neuroepithelial Neoplasms 23%
21. Survival 22%
22. Isocitrate Dehydrogenase 22%
23. Aquaporin 4 21%
24. Pleomorphic Adenoma 21%
25. Paraganglioma 20%
26. Neuroendocrine Tumors 19%
27. Methyltransferases 19%
28. Extracellular Matrix Proteins 18%
29. Laminin 17%
30. Meningioma 17%
31. Microglia 16%
32. alpha-Thalassemia 16%
33. Basement Membrane 15%
34. Cell Movement 15%
35. X-Linked Genes 15%
36. Differential Diagnosis 14%
37. Serotonin 13%
38. MicroRNAs 13%
39. DNA Fingerprinting 13%
40. Observer Variation 12%
41. Macrophages 12%
42. Genes 11%
43. Intellectual Disability 11%
44. Temozolomide 10%
45. Pediatrics 10%
46. Genome 9%
47. Ependymoma 9%
48. Proteins 9%
49. Brain 7%
50. Fluorescent Antibody Technique 7%